NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingNIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement
Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingGates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
Gates Foundation – CureVac, Global Access Commitments Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingGates Foundation – CureVac, Global Access Commitments Agreement
US Government – Ology Bioservices, COVID-19 Plasmid Procurement Agreement Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingUS Government – Ology Bioservices, COVID-19 Plasmid Procurement Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement
UK Secretary of State – Roche, REGN-COV2 Supply Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingUK Secretary of State – Roche, REGN-COV2 Supply Agreement
Peru Ministry of Health – Pfizer/BioNTech, COVID-19 Vaccine Binding Term Sheet Post author:GHIAA Editor Post published:June 28, 2021 Post category: Continue ReadingPeru Ministry of Health – Pfizer/BioNTech, COVID-19 Vaccine Binding Term Sheet
Dominican Republic Ministry of Health – Pfizer/BioNTech, COVID-19 Vaccine Binding Term Sheet Post author:GHIAA Editor Post published:June 3, 2021 Post category: Continue ReadingDominican Republic Ministry of Health – Pfizer/BioNTech, COVID-19 Vaccine Binding Term Sheet
UK Secretary of State – AstraZeneca, COVID-19 Vaccine Supply Agreement Post author:GHIAA Editor Post published:May 28, 2021 Post category: Continue ReadingUK Secretary of State – AstraZeneca, COVID-19 Vaccine Supply Agreement